NCT05773846View on ClinicalTrials.gov

A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

July 30, 2024

Study Completion Date

August 30, 2024

Conditions
Bunion
Interventions
DRUG

Ropivacaine

A long acting formulation of ropivacaine

Trial Locations (7)

33014

Clinical Pharmacology of Miami, Miami

45417

Midwest Clinical Research Center, Dayton

72211

Woodland International Research Group, Little Rock

75006

Legent Orthopedic Hopital, Carrolton

77043

Memorial Hermann Hospital, Houston

77401

First Surgical Hospital 4801 Bissonnet Street, Bellaire

78229

Endeavor Clinical Trials, San Antonio

Sponsors

Lead Sponsor

PainReform LTD
All Listed Sponsors
collaborator

Lotus Clinical Research, LLC

OTHER

lead

PainReform LTD

INDUSTRY

NCT05773846 - A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain | Biotech Hunter | Biotech Hunter